✦ LIBER ✦

Improvement of a dendritic cell-based tumour vaccine by an influenza virus

✍ Scribed by M. Sachet; J. Friedl; M. Hassler; M. Ploder; G. Stary; A. Stift; M. Bergmann

Book ID: 108713887
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 443 KB
Volume: 39
Category: Article
ISSN: 0014-2972
DOI: 10.1111/j.1365-2362.2009.02210.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trials of antitumor vaccination

Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory

✍ Volker Schirrmacher 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 367 KB

Dendritic cells are associated with augm

Dendritic cells are associated with augmentation of antigen sensitization by influenza A virus infection in mice

✍ Naomi Yamamoto; Shunsuke Suzuki; Akira Shirai; Motoyoshi Suzuki; Masatoshi Nakaz 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 3 views

Cross-protection against influenza virus

Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant

✍ Zhiwei Sui; Quanjiao Chen; Rui Wu; Hongbo Zhang; Mei Zheng; Hanzhong Wang; Ze Ch 📂 Article 📅 2010 🏛 Springer Vienna 🌐 English ⚖ 317 KB

A dendritic cell-based tumour vaccine fo

A dendritic cell-based tumour vaccine for lung cancer: full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro

✍ Q. Zhou; A.-L. Guo; C.-R. Xu; S.-J. An; Z. Wang; S.-Q. Yang; Y.-L. Wu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB

Induction of cross-protective immunity a

Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia

✍ Takeshi Ichinohe; Akira Ainai; Tomoyuki Nakamura; Yukihito Akiyama; Jun-ichi Mae 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views

## Abstract The identification of a safe and effective adjuvant that is able to enhance mucosal immune responses is necessary for the development of an efficient inactivated intranasal influenza vaccine. The present study demonstrated the effectiveness of extracts of mycelia derived from edible mus

Immune control of an SIV challenge by a

Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys

✍ Liu, Jinyan; O’Brien, Kara L.; Lynch, Diana M.; Simmons, Nathaniel L.; La Porte, 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 204 KB